« US Stocks Down Ahead Of Data; Credit Spreads Widen
Fitch raises Raytheon outlook to positive from stable »

High court: No action on ruling favoring drug fraud patients

SAN FRANCISCO (MarketWatch) — Supreme Court justices were split on a lower court ruling favoring patients who sued a drug maker over a diabetes treatment that allegedly harmed them, The Associated Press reported Monday. With Chief Justice John Roberts not participating, the court was split 4-4 on the lower court ruling, leaving it intact, the news service said. The suits concern the diabetes drug Rezulin made by Warner-Lambert, which is now owned by Pfizer Inc . Plaintiffs allege Warner-Lambert committed fraud by misleading regulators to get the drug approved, the AP reported.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

Original post by Forextvblog

This entry was posted on Monday, March 3rd, 2008 at 10:52 am and is filed under Daily Forex Analysis. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.

Leave a Reply